Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

On Monday, Aclaris Therapeutics, Inc. (NASDAQ:ACRS) entered into an exclusive license agreement with Biosion Inc for ...

Plug Power downgraded at BTIG Research, citing need for more product sales to boost margins in the hydrogen market.

Conservative media personality Megyn Kelly on Monday blasted “Morning Joe” hosts Joe Scarborough and Mika Brzezinski, calling ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

Perhaps channeling the market's desire for some amount of certainty, BTIG director of policy research Isaac Boltansky added in a recent live Yahoo Finance appearance that "I hope by the end of the ...

Chris Fritz, Senior Vice President of Financial Planning and Analysis at Tenable, is scheduled to attend the BTIG Virtual Software Forum. Vintz is also scheduled to attend the Barclays Global ...

On Monday, DoorDash Inc (DASH) stock saw a modest uptick, ending the day at $172.73 which represents a slight increase of $3.30 or 1.95% from the prior close of $169.43. The stock opened at $169.78 ...